Cargando…

Safety and Efficacy of Repeat Open-Label AbobotulinumtoxinA Treatment in Pediatric Cerebral Palsy

This was a prospective, repeat-treatment, open-label study (NCT01251380) of abobotulinumtoxinA for the management of lower limb spasticity in children who had completed a double-blind study. Children (2-17 years) received injections into the gastrocnemius-soleus complex, and other distal and proxima...

Descripción completa

Detalles Bibliográficos
Autores principales:	Delgado, Mauricio R., Bonikowski, Marcin, Carranza, Jorge, Dabrowski, Edward, Matthews, Dennis, Russman, Barry, Tilton, Ann, Velez, Juan Carlos, Grandoulier, Anne-Sophie, Picaut, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652649/ https://www.ncbi.nlm.nih.gov/pubmed/28914131 http://dx.doi.org/10.1177/0883073817729918

Ejemplares similares

Efficacy and safety of abobotulinumtoxinA for upper limb spasticity in children with cerebral palsy: a randomized repeat‐treatment study
por: Delgado, Mauricio R, et al.
Publicado: (2020)

AbobotulinumtoxinA (Dysport(®)) Improves Function According to Goal Attainment in Children With Dynamic Equinus Due to Cerebral Palsy
por: Tilton, Ann, et al.
Publicado: (2017)

Muscle Selection and Dosing in a Phase 3, Pivotal Study of AbobotulinumtoxinA Injection in Upper Limb Muscles in Children With Cerebral Palsy
por: Oleszek, Joyce, et al.
Publicado: (2021)

Effects of repeated abobotulinumtoxinA injections in upper limb spasticity
por: Gracies, Jean‐Michel, et al.
Publicado: (2017)

The Effect of Repeated abobotulinumtoxinA (Dysport®) Injections on Walking Velocity in Persons with Spastic Hemiparesis Caused by Stroke or Traumatic Brain Injury
por: Esquenazi, Alberto, et al.
Publicado: (2020)

Efficacy and safety of abobotulinumtoxinA in spastic lower limb: Randomized trial and extension
por: Gracies, Jean-Michel, et al.
Publicado: (2017)

The Practical Use of AbobotulinumtoxinA in Aesthetics
por: Kane, Michael A. C., et al.
Publicado: (2017)

New Uses of AbobotulinumtoxinA in Aesthetics
por: Schlessinger, Joel, et al.
Publicado: (2017)

AbobotulinumtoxinA: A 25-Year History
por: Monheit, Gary D., et al.
Publicado: (2017)

Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical Studies
por: Esquenazi, Alberto, et al.
Publicado: (2020)

Repeated Full-Face Aesthetic Combination Treatment With AbobotulinumtoxinA, Hyaluronic Acid Filler, and Skin-Boosting Hyaluronic Acid After Monotherapy With AbobotulinumtoxinA or Hyaluronic Acid Filler
por: Cartier, Hugues, et al.
Publicado: (2020)

Introduction to the Supplement: A Review of AbobotulinumtoxinA (Dysport)
por: Dover, Jeffrey S.
Publicado: (2017)

Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Hemiparesis in Adults with Lower Limb Spasticity Previously Treated With Other Botulinum Toxins: A Secondary Analysis of a Randomized Controlled Trial
por: Esquenazi, Alberto, et al.
Publicado: (2020)

Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration
por: Nestor, Mark, et al.
Publicado: (2017)

AbobotulinumtoxinA (Dysport(®)), OnabotulinumtoxinA (Botox(®)), and IncobotulinumtoxinA (Xeomin(®)) Neurotoxin Content and Potential Implications for Duration of Response in Patients
por: Field, Malgorzata, et al.
Publicado: (2018)

GOAL ATTAINMENT AFTER TREATMENT WITH ABOBOTULINUMTOXINA AND A TAILORED HOME THERAPY PROGRAMME IN CHILDREN WITH UPPER LIMB SPASTICITY: DESCRIPTIVE, EXPLORATORY ANALYSIS OF A LARGE RANDOMIZED, CONTROLLED STUDY
por: CARRANZA-DEL RÍO, Jorge, et al.
Publicado: (2022)

Impact of abobotulinumtoxinA on the clinical features of cervical dystonia in routine practice
por: Trosch, Richard M., et al.
Publicado: (2020)

Conversion to AbobotulinumtoxinA Increases Waning Time and Efficacy for Cervical Dystonia
por: Samotus, Olivia, et al.
Publicado: (2023)

A Cost-Effectiveness and Budget Impact Analysis of AbobotulinumtoxinA in Greece
por: Nomikos, Nikolaos, et al.
Publicado: (2023)

Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study
por: Wu, Yan, et al.
Publicado: (2022)

Correction: Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study
por: Wu, Yan, et al.
Publicado: (2023)

Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Blepharospasm and Hemifacial Spasm
por: Dashtipour, Khashayar, et al.
Publicado: (2015)

OnabotulinumtoxinA and AbobotulinumtoxinA Dose Conversion: A Systematic Literature Review
por: Dashtipour, Khashayar, et al.
Publicado: (2015)

Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Lower Limb Spasticity
por: Dashtipour, Khashayar, et al.
Publicado: (2016)

Safety and Patient Satisfaction of AbobotulinumtoxinA for Aesthetic Use: A Systematic Review
por: Cohen, Joel L., et al.
Publicado: (2017)

Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United Kingdom
por: Muthukumar, Madhusubramanian, et al.
Publicado: (2017)

Use of AbobotulinumtoxinA in Adults with Cervical Dystonia: A Systematic Literature Review
por: Fasano, Alfonso, et al.
Publicado: (2020)

Guided Self-rehabilitation Contracts Combined With AbobotulinumtoxinA in Adults With Spastic Paresis
por: Gracies, Jean-Michel, et al.
Publicado: (2021)

AbobotulinumtoxinA in the management of cervical dystonia in the United Kingdom: a budget impact analysis
por: Abogunrin, Seye, et al.
Publicado: (2015)

Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Adult Upper Limb Spasticity
por: Dashtipour, Khashayar, et al.
Publicado: (2015)

Intradermal Micro-Dosing of AbobotulinumtoxinA for Face-Lifting: How Long Does It Last?
por: Wanitphakdeedecha, Rungsima, et al.
Publicado: (2020)

Effectiveness of AbobotulinumtoxinA in Post-stroke Upper Limb Spasticity in Relation to Timing of Treatment
por: Wissel, Jörg, et al.
Publicado: (2020)

AbobotulinumtoxinA Doses in Upper and Lower Limb Spasticity: A Systematic Literature Review
por: Schnitzler, Alexis, et al.
Publicado: (2022)

Correction: Field, M. et al. AbobotulinumtoxinA (Dysport(®)), OnabotulinumtoxinA (Botox(®)), and IncobotulinumtoxinA (Xeomin(®)) Neurotoxin Content and Potential Implications for Duration of Response in Patients
por: Field, Malgorzata, et al.
Publicado: (2019)

Spectrum of practice in the routine management of cervical dystonia with abobotulinumtoxinA: findings from three prospective open-label observational studies
por: Misra, Vijay P., et al.
Publicado: (2018)

Transient Improvement after Switch to Low Doses of RimabotulinumtoxinB in Patients Resistant to AbobotulinumtoxinA
por: Hefter, Harald, et al.
Publicado: (2020)

Real-World, Retrospective, Multicenter, Observational Study on the Use of the First Liquid AbobotulinumtoxinA in Italy
por: Di Gregorio, Carlo, et al.
Publicado: (2023)

Significantly Increased Patient Satisfaction Following Liquid Formulation AbobotulinumtoxinA Treatment in Glabellar Lines: FACE-Q Outcomes From a Phase 3 Clinical Trial
por: Ascher, Benjamin, et al.
Publicado: (2020)

Early AbobotulinumtoxinA (Dysport(®)) in Post-Stroke Adult Upper Limb Spasticity: ONTIME Pilot Study
por: Rosales, Raymond L, et al.
Publicado: (2018)

Economics of botulinum toxin therapy: influence of the abobotulinumtoxinA package size on the costs of botulinum toxin therapy
por: Dressler, Dirk, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mnh162hs0aok35lujas1vpnfs0